Literature DB >> 20565314

Handling test of eye drop dispenser--comparison of unit-dose pipettes with conventional eye drop bottles.

Minna Parkkari1, Terho Latvala, Auli Ropo.   

Abstract

PURPOSE: The aims of this study were to investigate how elderly people handle single-use eye drop dispensers (unit-dose pipettes) and to compare the performance with conventional eye drop bottles.
METHODS: In this open-label study, the handling of unit-dose pipettes and conventional eye drop bottles was compared in 41 elderly people who had little or no prior regular use of eye drop dispensers. The participants tested both types of dispenser once, and the following 7 variables were studied: ease/difficulty of opening the dispenser; influence of the size for handling of the dispenser; influence of the shape for handling of the dispenser; observation of the contents in the dispenser; the feeling of the dispenser in the hand; ease/difficulty of drop instillation on the eye from the dispenser; and overall performance of the eye drop dispenser. The dispensers contained isotonic saline, and a visual analog scale was used for assessment of each of the above variables.
RESULTS: The mean age of the participants was 73 years. A statistically significant difference in favor of the unit-dose pipettes was found with respect to observation of the contents in the dispenser, ease of administration, and the overall performance. Women regarded the unit-dose pipettes generally better than the bottles, but such a difference was not seen in men.
CONCLUSIONS: The study participants managed the unit-dose pipettes at least as well as the conventional eye drop bottles. If anything, the unit-dose pipettes appeared to be easier to use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20565314      PMCID: PMC2893744          DOI: 10.1089/jop.2009.0111

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  15 in total

1.  Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits.

Authors:  P J Pisella; K Fillacier; P P Elena; C Debbasch; C Baudouin
Journal:  Ophthalmic Res       Date:  2000 Jan-Feb       Impact factor: 2.892

2.  Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile.

Authors:  D C Broadway; I Grierson; C O'Brien; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1994-11

3.  Toxic endothelial cell destruction from intraocular benzalkonium chloride.

Authors:  H Liu; I Routley; K D Teichmann
Journal:  J Cataract Refract Surg       Date:  2001-11       Impact factor: 3.351

4.  Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study.

Authors:  Pierre-Jean Pisella; Caroline Debbasch; Pascale Hamard; Catherine Creuzot-Garcher; Patrice Rat; Françoise Brignole; Christophe Baudouin
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-05       Impact factor: 4.799

5.  Corneal and conjunctival changes caused by commonly used glaucoma medications.

Authors:  Robert J Noecker; Lisa A Herrygers; Raana Anwaruddin
Journal:  Cornea       Date:  2004-07       Impact factor: 2.651

6.  Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients.

Authors:  Thomas S Dietlein; Jens F Jordan; Christoph Lüke; Andrea Schild; Sven Dinslage; Guenter K Krieglstein
Journal:  Acta Ophthalmol       Date:  2008-05-20       Impact factor: 3.761

7.  In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells.

Authors:  Pascale Hamard; Catherine Blondin; Caroline Debbasch; Jean-Michel Warnet; Christophe Baudouin; Françoise Brignole
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-07       Impact factor: 3.117

8.  Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

Authors:  D C Broadway; I Grierson; C O'Brien; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1994-11

9.  Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol.

Authors:  Yoko Goto; Nobuhiro Ibaraki; Kensaku Miyake
Journal:  Arch Ophthalmol       Date:  2003-06

10.  ESCRS Binkhorst lecture 2002: Pseudophakic preservative maculopathy.

Authors:  Kensaku Miyake; Nobuhiro Ibaraki; Yoko Goto; Shin Oogiya; Junko Ishigaki; Ichiro Ota; Sampei Miyake
Journal:  J Cataract Refract Surg       Date:  2003-09       Impact factor: 3.351

View more
  4 in total

1.  Epidemiological aspects of ocular superglue injuries.

Authors:  Seyed Ali Tabatabaei; Shokoufeh Modanloo; Arezoo Mohammadkhani Ghiyasvand; Abolghasem Pouryani; Mohammad Soleimani; Seyed Mehdi Tabatabaei; Ahmad Reza Pakrah; Hamideh Masarat
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

Review 2.  Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.

Authors:  Gábor Holló; Andreas Katsanos; Kostas G Boboridis; Murat Irkec; Anastasios G P Konstas
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

3.  Comparison of the Usability of Eye Drop Aids and the Conventional Bottle.

Authors:  Gali Brand; Idan Hecht; Zvia Burgansky-Eliash; Liron Naftali Ben Haim; Duncan Leadbetter; Oriel Spierer; Asaf Achiron
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

Review 4.  Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future.

Authors:  Anastasios G Konstas; Leopold Schmetterer; Andreas Katsanos; Cindy M L Hutnik; Gábor Holló; Luciano Quaranta; Miguel A Teus; Hannu Uusitalo; Norbert Pfeiffer; L Jay Katz
Journal:  Adv Ther       Date:  2020-10-27       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.